Thomas A. Mitro
2016
In 2016, Thomas A. Mitro earned a total compensation of $1.6M as President & Chief Operating Officer at Aerie Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
| Bonus | $191,497 |
|---|---|
| Option Awards | $845,462 |
| Salary | $403,150 |
| Stock Awards | $198,194 |
| Total | $1,638,303 |
Mitro received $845.5K in option awards, accounting for 52% of the total pay in 2016.
Mitro also received $191.5K in bonus, $403.2K in salary and $198.2K in stock awards.
Rankings
In 2016, Thomas A. Mitro's compensation ranked 5,838th out of 14,075 executives tracked by ExecPay. In other words, Mitro earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,838 out of 14,075 | 59th |
Division Manufacturing | 2,118 out of 5,488 | 61st |
Major group Chemicals And Allied Products | 693 out of 1,900 | 64th |
Industry group Drugs | 522 out of 1,543 | 66th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 287 | 67th |
Source: SEC filing on April 27, 2017.
Mitro's colleagues
We found three more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2016.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019